These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 23190184)

  • 1. Pharmacokinetic profiles for oral and subcutaneous methotrexate in patients with Crohn's disease.
    Wilson A; Patel V; Chande N; Ponich T; Urquhart B; Asher L; Choi Y; Tirona R; Kim RB; Gregor JC
    Aliment Pharmacol Ther; 2013 Feb; 37(3):340-5. PubMed ID: 23190184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of low dose methotrexate bioavailability: oral solution, oral tablet, subcutaneous and intramuscular dosing.
    Jundt JW; Browne BA; Fiocco GP; Steele AD; Mock D
    J Rheumatol; 1993 Nov; 20(11):1845-9. PubMed ID: 8308768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcutaneous administration of methotrexate with a prefilled autoinjector pen results in a higher relative bioavailability compared with oral administration of methotrexate.
    Pichlmeier U; Heuer KU
    Clin Exp Rheumatol; 2014; 32(4):563-71. PubMed ID: 24983446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Splitting high-dose oral methotrexate improves bioavailability: a pharmacokinetic study in patients with rheumatoid arthritis.
    Hoekstra M; Haagsma C; Neef C; Proost J; Knuif A; van de Laar M
    J Rheumatol; 2006 Mar; 33(3):481-5. PubMed ID: 16463431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single center experience of methotrexate in the treatment of Crohn's disease and ulcerative colitis: a case for subcutaneous administration.
    Nathan DM; Iser JH; Gibson PR
    J Gastroenterol Hepatol; 2008 Jun; 23(6):954-8. PubMed ID: 17559377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability of oral vs. subcutaneous low-dose methotrexate in patients with Crohn's disease.
    Kurnik D; Loebstein R; Fishbein E; Almog S; Halkin H; Bar-Meir S; Chowers Y
    Aliment Pharmacol Ther; 2003 Jul; 18(1):57-63. PubMed ID: 12848626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability of higher dose methotrexate comparing oral and subcutaneous administration in patients with rheumatoid arthritis.
    Hoekstra M; Haagsma C; Neef C; Proost J; Knuif A; van de Laar M
    J Rheumatol; 2004 Apr; 31(4):645-8. PubMed ID: 15088287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of oral methotrexate in paediatric Crohn's disease: a multicentre propensity score study.
    Turner D; Doveh E; Cohen A; Wilson ML; Grossman AB; Rosh JR; Lu Y; Bousvaros A; Deslandres C; Noble A; Baldassano RN; Levine A; Lerner A; Wilson DC; Griffiths AM
    Gut; 2015 Dec; 64(12):1898-904. PubMed ID: 25416066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
    Hroch M; Chladek J; Simkova M; Vaneckova J; Grim J; Martinkova J
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of food on the bioavailability of oral methotrexate in children.
    Dupuis LL; Koren G; Silverman ED; Laxer RM
    J Rheumatol; 1995 Aug; 22(8):1570-3. PubMed ID: 7473485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability and bioequivalence of two oral formulations of alendronate sodium 70 mg: an open-label, randomized, two-period crossover comparison in healthy Korean adult male volunteers.
    Rhim SY; Park JH; Park YS; Lee MH; Kim DS; Shaw LM; Yang SC; Kang JS
    Clin Ther; 2009 May; 31(5):1037-45. PubMed ID: 19539104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate intolerance in oral and subcutaneous administration in patients with juvenile idiopathic arthritis: a cross-sectional, observational study.
    van Dijkhuizen EH; Pouw JN; Scheuern A; Hügle B; Hardt S; Ganser G; Kümmerle-Deschner JB; Horneff G; Holzinger D; Bulatović Ćalasan M; Wulffraat NM
    Clin Exp Rheumatol; 2016; 34(1):148-54. PubMed ID: 26843067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate bioavailability after oral and subcutaneous dministration in children with juvenile idiopathic arthritis.
    Tuková J; Chládek J; Nemcová D; Chládková J; Dolezalová P
    Clin Exp Rheumatol; 2009; 27(6):1047-53. PubMed ID: 20149329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term methotrexate for Crohn's disease: safety and efficacy in clinical practice.
    Domènech E; Mañosa M; Navarro M; Masnou H; Garcia-Planella E; Zabana Y; Cabré E; Gassull MA
    J Clin Gastroenterol; 2008 Apr; 42(4):395-9. PubMed ID: 18277899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind, parallel, single-site pilot trial to compare two different starting doses of methotrexate in methotrexate-naïve adult patients with rheumatoid arthritis.
    Hobl EL; Mader RM; Jilma B; Duhm B; Mustak M; Bröll H; Högger P; Erlacher L
    Clin Ther; 2012 May; 34(5):1195-203. PubMed ID: 22516039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy with methotrexate and hydroxychloroquine for rheumatoid arthritis increases exposure to methotrexate.
    Carmichael SJ; Beal J; Day RO; Tett SE
    J Rheumatol; 2002 Oct; 29(10):2077-83. PubMed ID: 12375315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined oral cyclosporin and methotrexate therapy in patients with rheumatoid arthritis elevates methotrexate levels and reduces 7-hydroxymethotrexate levels when compared with methotrexate alone.
    Fox RI; Morgan SL; Smith HT; Robbins BA; Choc MG; Baggott JE
    Rheumatology (Oxford); 2003 Aug; 42(8):989-94. PubMed ID: 12730515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examination of pharmacokinetic variables in a cohort of patients with rheumatoid arthritis beginning therapy with methotrexate compared with a cohort receiving the drug for a mean of 81 months.
    Kremer JM; Petrillo GF; Hamilton RA
    J Rheumatol; 1995 Jan; 22(1):41-4. PubMed ID: 7699679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioequivalence and tolerability of two clopidogrel salt preparations, besylate and bisulfate: a randomized, open-label, crossover study in healthy Korean male subjects.
    Kim SD; Kang W; Lee HW; Park DJ; Ahn JH; Kim MJ; Kim EY; Kim SW; Nam HS; Na HJ; Yoon YR
    Clin Ther; 2009 Apr; 31(4):793-803. PubMed ID: 19446152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, open-label, two-period, crossover bioavailability study of two oral formulations of tacrolimus in healthy Korean adults.
    Park K; Kim YS; Kwon KI; Park MS; Lee YJ; Kim KH
    Clin Ther; 2007 Jan; 29(1):154-62. PubMed ID: 17379055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.